SCHEMBL29368268

SCHEMBL29368268

CC(C)C[C@H](NC(=O)[C@H](C)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)O

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SLC15A2 Q16348 1/20 0.53
▸ ITGB2 P05107 3/20 0.53
▸ ICAM1 P05362 3/20 0.53
▸ ITGAL P20701 3/20 0.53
▸ CYP3A4 P08684 1/20 0.51
▸ SLC7A5 Q01650 1/20 0.51
▸ REN P00797 5/20 0.51
▸ CA1 P00915 2/20 0.50
▸ CA2 P00918 2/20 0.50
▸ ERAP2 Q6P179 1/20 0.49
▸ ERAP1 Q9NZ08 1/20 0.49
▸ LNPEP Q9UIQ6 1/20 0.49
▸ ACE2 Q9BYF1 1/20 0.48
▸ SLC6A5 Q9Y345 1/20 0.47
▸ HRH4 Q9H3N8 2/20 0.46
▸ HRH3 Q9Y5N1 2/20 0.46
▸ MEN1 O00255 1/20 0.46
▸ ALDH1A1 P00352 1/20 0.46
▸ GLA P06280 1/20 0.46
▸ KMT2A Q03164 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1161012 0.93 ITGB2 (0.59) SLC15A2ITGB2ICAM1ITGALCYP3A4
SCHEMBL1229751 0.93 ITGB2 (0.59) SLC15A2ITGB2ICAM1ITGALCYP3A4
SCHEMBL308989 0.93 ITGB2 (0.59) SLC15A2ITGB2ICAM1ITGALCYP3A4
SCHEMBL29349749 0.92 CYP3A4 (0.53) SLC15A2ITGB2ICAM1ITGALCYP3A4
SCHEMBL27469252 0.92 ITGB2 (0.58) SLC15A2ITGB2ICAM1ITGALCYP3A4
SCHEMBL21828702 0.88 CYP3A4 (0.57) SLC15A2ITGB2ICAM1ITGALCYP3A4
SCHEMBL30595016 0.88 CYP3A4 (0.57) SLC15A2ITGB2ICAM1ITGALCYP3A4
SCHEMBL21838312 0.86 SLC15A2 (0.54) SLC15A2ITGB2ICAM1ITGALCYP3A4
SCHEMBL29728766 0.86 CYP3A4 (0.60) SLC15A2ITGB2ICAM1ITGALCYP3A4
SCHEMBL27806348 0.86 CYP3A4 (0.60) SLC15A2ITGB2ICAM1ITGALCYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 36 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118821420-A Construction method of intelligent stealth system of complex system equipment 南京邮电大学 2024-10-22 — — CN claimed
CN-116785450-A Maytansinoid derivatives with self-cleaving peptide linker and conjugates thereof 伊缪诺金公司 2023-09-22 — — CN claimed
CN-115655701-A Method and system for testing functions of flow-limiting check valve 国检测试控股集团上海有限公司 2023-01-31 — — CN claimed
CN-115174056-A Chameleon signature generation method and device based on SM9 signature 武汉大学 2022-10-11 — — CN claimed
EP-4626489-A1 PCTA DERIVATIVES, CONJUGATES THEREOF AND USES THEREOF Novartis AG (CH) 2025-10-08 — — EP disclosed
US-20250111889-A1 DE NOVO DESIGNED MACROCYCLIC OLIGOAMIDES UNIVERSITY OF WASHINGTON 2025-04-03 — — US disclosed
US-20240391951-A1 NOVEL METHODS FOR PRODUCING PEPTIDE THIOESTER AND PEPTIDE GLYTECH INC (JP) 2024-11-28 — — US disclosed
CN-117912601-B Method and device for displaying molecular conformation and medium 苏州腾迈医药科技有限公司 2024-11-01 — — CN disclosed
EP-4453088-A1 SOFT POLYOLEFIN COMPOSITION Basell Poliolefine Italia S.r.l. (IT) 2024-10-30 — — EP disclosed
CN-118821420-A Construction method of intelligent stealth system of complex system equipment 南京邮电大学 2024-10-22 — — CN disclosed
US-12103947-B2 Methods for producing peptide thioester and peptide GLYTECH, INC. (JP) 2024-10-01 — — US disclosed
WO-2024116053-A1 PCTA DERIVATIVES, CONJUGATES THEREOF AND USES THEREOF NOVARTIS AG (CH) 2024-06-06 — — WO disclosed
CN-115073566-A Specific immunogenic peptide fragment of helicobacter pylori 河北医科大学第四医院 2022-09-20 — — CN disclosed
CN-114972562-A Rapid magnetic resonance imaging method combining coil sensitivity estimation and image reconstruction 厦门大学 2022-08-30 — — CN disclosed
CN-114394987-B Preparation method of trialkyl lithium borohydride 沧州临港星辰化工有限公司 2022-08-05 — — CN disclosed
EP-3986893-A1 PHARMACEUTICALLY ACTIVE PYRAZOLO-PYRIDONE MODULATORS OF DCN1/2-MEDIATED CULLIN NEDDYLATION University Of Kentucky Research Foundation (US) 2022-04-27 — — EP disclosed
CN-216247261-U Test device for researching non-common-plate common-rail common-building tunnel model 中铁十四局集团有限公司 2022-04-08 — — CN disclosed
CN-114187467-A Lung nodule benign and malignant classification method and device based on CNN model 电子科技大学 2022-03-15 — — CN disclosed
CN-215767800-U Assembled full-section bed sand sampling device 交通运输部天津水运工程科学研究所 2022-02-08 — — CN disclosed
CN-114001990-A Test device and method for researching non-shared-plate common-rail co-building tunnel model 中铁十四局集团有限公司 2022-02-01 — — CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250111889-A1 DE NOVO DESIGNED MACROCYCLIC OLIGOAMIDES DHFR, CCNH, ODC1 SLC15A2 3554/4885ITGB2 4171/4885ICAM1 4379/4885
US-12103947-B2 Methods for producing peptide thioester and peptide QPCT, QPCTL, PTMS SLC15A2 2888/4885ITGB2 4860/4885ICAM1 4749/4885
US-20240391951-A1 NOVEL METHODS FOR PRODUCING PEPTIDE THIOESTER AND PEPTIDE QPCT, PTMS, QPCTL SLC15A2 2832/4885ITGB2 4856/4885ICAM1 4764/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback